©The Author(s) 2000.
World J Gastroenterol. Jun 15, 2000; 6(3): 324-325
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.324
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.324
Table 4 Hp eradication with CBS triple therapy
| Authors | CBS | Amo | Met | Eradication (%) | Side effect |
| Jia BQ[13] | 120 qid × 14 | 250 qid × 14 | 200 qid × 14 | 328/440 (87) | 7.8% |
| Jia BQ[13] | 240 bid × 14 | 500 bid × 14 | 400 bid × 14 | 139/156 (89) | 7.8% |
| Chen SP[14] | 240 bid × 14 | 1000 bid × 14 | 400 bid × 14 | 33/46 (71) | |
| Li QN[15] | 240 bid × 14 | 500 bid × 14 | 400 bid × 14 | 13/16 (81) | 37.5% |
| Geng Z[16] | 110 qid × 14 | 500 qid × 14 | 200 qid × 14 | 64/76 (84) | |
| Zhou LY[17] | 120 qid × 14 | 250 qid × 14 | 200 qid × 14 | 56/73 (77) | |
| Li YY[18] | 120 qid × 14 | 250 qid × 14 | 200 qid × 14 | 20/25 (80) | 28% |
- Citation: Li YY, Sha WH. Treatment of Helicobactor pylori infection: analysis of Chinese clinical trials. World J Gastroenterol 2000; 6(3): 324-325
- URL: https://www.wjgnet.com/1007-9327/full/v6/i3/324.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i3.324